CX3CR1 regulates gut microbiota and metabolism. A risk factor of type 2 diabetes
- PMID: 33754166
- DOI: 10.1007/s00592-021-01682-1
CX3CR1 regulates gut microbiota and metabolism. A risk factor of type 2 diabetes
Abstract
Objective: The intestinal microbiota to immune system crosstalk is a major regulator of metabolism and hence metabolic diseases. An impairment of the chemokine receptor CX3CR1, as a key regulator shaping intestinal microbiota under normal chow feeding, could be one of the early events of dysglycemia.
Methods: We studied the gut microbiota ecology by sequencing the gut and tissue microbiota. We studied its role in energy metabolism in CX3CR1-deficent and control mice using various bioassays notably the glycemic regulation during fasting and the respiratory quotient as two highly sensitive physiological features. We used antibiotics and prebiotics treatments, and germ free mouse colonization.
Results: We identify that CX3CR1 disruption impairs gut microbiota ecology and identified a specific signature associated to the genotype. The glycemic control during fasting and the respiratory quotient throughout the day are deeply impaired. A selected four-week prebiotic treatment modifies the dysbiotic microbiota and improves the fasting state glycemic control of the CX3CR1-deficent mice and following a glucose tolerance test. A 4 week antibiotic treatment also improves the glycemic control as well. Eventually, germ free mice colonized with the microbiota from CX3CR1-deficent mice developed glucose intolerance.
Conclusions: CX3CR1 is a molecular mechanism in the control of the gut microbiota ecology ensuring the maintenance of a steady glycemia and energy metabolism. Its impairment could be an early mechanism leading to gut microbiota dysbiosis and the onset of metabolic disease.
Keywords: Fractalkine; Germ free mice; Intestinal immune system; Metabolic diseases; Microbiota.
© 2021. Springer-Verlag Italia S.r.l., part of Springer Nature.
Similar articles
-
Liraglutide targets the gut microbiota and the intestinal immune system to regulate insulin secretion.Acta Diabetol. 2021 Jul;58(7):881-897. doi: 10.1007/s00592-020-01657-8. Epub 2021 Mar 15. Acta Diabetol. 2021. PMID: 33723651
-
Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism.Br J Nutr. 2020 May 28;123(10):1127-1137. doi: 10.1017/S0007114520000380. Epub 2020 Feb 3. Br J Nutr. 2020. PMID: 32008579
-
CX3CR1 is a gatekeeper for intestinal barrier integrity in mice: Limiting steatohepatitis by maintaining intestinal homeostasis.Hepatology. 2015 Nov;62(5):1405-16. doi: 10.1002/hep.27982. Epub 2015 Sep 2. Hepatology. 2015. PMID: 26178698
-
[Gut microbiota and immune crosstalk in metabolic disease].Biol Aujourdhui. 2017;211(1):1-18. doi: 10.1051/jbio/2017008. Epub 2017 Jul 6. Biol Aujourdhui. 2017. PMID: 28682223 Review. French.
-
Modulation of the gut microbiota-adipose tissue-muscle interactions by prebiotics.J Endocrinol. 2021 Apr;249(1):R1-R23. doi: 10.1530/JOE-20-0499. J Endocrinol. 2021. PMID: 33502337 Review.
Cited by
-
A gut pathobiont regulates circulating glycine and host metabolism in a twin study comparing vegan and omnivorous diets.medRxiv [Preprint]. 2025 Jan 30:2025.01.08.25320192. doi: 10.1101/2025.01.08.25320192. medRxiv. 2025. PMID: 39830242 Free PMC article. Preprint.
-
Bacterial lipopolysaccharide related genes signature as potential biomarker for prognosis and immune treatment in gastric cancer.Sci Rep. 2023 Sep 23;13(1):15916. doi: 10.1038/s41598-023-43223-6. Sci Rep. 2023. PMID: 37741901 Free PMC article.
References
-
- Hotamisligil GS (2017) Inflammation, metaflammation and immunometabolic disorders. Nature 542(7640):177–185. https://doi.org/10.1038/nature21363 - DOI - PubMed
-
- Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, Almeida M, Arumugam M, Batto JM, Kennedy S, Leonard P, Li J, Burgdorf K, Grarup N, Jorgensen T, Brandslund I, Nielsen HB, Juncker AS, Bertalan M, Levenez F, Pons N, Rasmussen S, Sunagawa S, Tap J, Tims S, Zoetendal EG, Brunak S, Clement K, Dore J, Kleerebezem M, Kristiansen K, Renault P, Sicheritz-Ponten T, de Vos WM, Zucker JD, Raes J, Hansen T, Meta HITc, Bork P, Wang J, Ehrlich SD, Pedersen O, (2013) Richness of human gut microbiome correlates with metabolic markers. Nature 500(7464):541–546. https://doi.org/10.1038/nature12506 - DOI - PubMed
-
- Burcelin R, Garidou L, Pomie C (2012) Immuno-microbiota cross and talk: the new paradigm of metabolic diseases. Semin Immunol 24(1):67–74. https://doi.org/10.1016/j.smim.2011.11.011 - DOI - PubMed
-
- McPhee JB, Schertzer JD (2015) Immunometabolism of obesity and diabetes: microbiota link compartmentalized immunity in the gut to metabolic tissue inflammation. Clin Sci (Lond) 129(12):1083–1096. https://doi.org/10.1042/CS20150431 - DOI
-
- Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, Mende DR, Li J, Xu J, Li S, Li D, Cao J, Wang B, Liang H, Zheng H, Xie Y, Tap J, Lepage P, Bertalan M, Batto JM, Hansen T, Le Paslier D, Linneberg A, Nielsen HB, Pelletier E, Renault P, Sicheritz-Ponten T, Turner K, Zhu H, Yu C, Jian M, Zhou Y, Li Y, Zhang X, Qin N, Yang H, Wang J, Brunak S, Dore J, Guarner F, Kristiansen K, Pedersen O, Parkhill J, Weissenbach J, Bork P, Ehrlich SD (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464(7285):59–65. https://doi.org/10.1038/nature08821 - DOI - PubMed - PMC
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials